Methylation sites of human papillomavirus 16 as potential biomarkers for cervical cancer progression

ObjectiveTo investigate the methylation levels at 13 specific sites of the human papillomavirus 16 (HPV16) L1 gene as potential biomarkers for the diagnosis of cervical cancer.MethodsSamples were collected from the gynecological outpatient and inpatient departments of the Xinjiang Uygur Autonomous R...

Full description

Saved in:
Bibliographic Details
Main Authors: Sha Ji, Nannan Ji
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2025.1481621/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832585055399051264
author Sha Ji
Nannan Ji
author_facet Sha Ji
Nannan Ji
author_sort Sha Ji
collection DOAJ
description ObjectiveTo investigate the methylation levels at 13 specific sites of the human papillomavirus 16 (HPV16) L1 gene as potential biomarkers for the diagnosis of cervical cancer.MethodsSamples were collected from the gynecological outpatient and inpatient departments of the Xinjiang Uygur Autonomous Region People’s Hospital. A total of 107 women participated in this study, including 54 with cervical cancer (32 Uygur, 22 Han) and 53 with cervical inflammation (32 Uygur, 21 Han). Methylation analysis was performed using pyrosequencing to quantitatively assess methylation levels at specified CpG sites within the HPV16 L1 gene.ResultsHigh methylation levels were predominantly observed at sites 5927, 5963 and 6367 in cervical cancer cells compared with inflammatory cells. Methylation patterns exhibited no significant differences between the Han and Uygur ethnic groups but correlated with viral load and age within each group. Receiver operating characteristic curve analyses of these methylation sites indicated high diagnostic accuracy in distinguishing between high-grade lesions and less severe conditions.ConclusionsMethylation of specific CpG sites in the HPV16 L1 gene holds promise as a biomarker for cervical cancer progression. The gene locus at position 6367 has important features in the methylation pattern of cervical cancer, and high accuracy shown in diagnosis make it a potential biomarker for early diagnosis of cervical cancer.
format Article
id doaj-art-3480cec8d6b049a9aa8a80f8ab46af75
institution Kabale University
issn 2234-943X
language English
publishDate 2025-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj-art-3480cec8d6b049a9aa8a80f8ab46af752025-01-27T05:14:37ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2025-01-011510.3389/fonc.2025.14816211481621Methylation sites of human papillomavirus 16 as potential biomarkers for cervical cancer progressionSha Ji0Nannan Ji1Department of Gynecology, Xinjiang Uygur Autonomous Region People’s Hospital, Urumqi, Xinjiang, ChinaOperating Room, The First Affiliated Hospital of Shihezi University, Shihezi, Xinjiang, ChinaObjectiveTo investigate the methylation levels at 13 specific sites of the human papillomavirus 16 (HPV16) L1 gene as potential biomarkers for the diagnosis of cervical cancer.MethodsSamples were collected from the gynecological outpatient and inpatient departments of the Xinjiang Uygur Autonomous Region People’s Hospital. A total of 107 women participated in this study, including 54 with cervical cancer (32 Uygur, 22 Han) and 53 with cervical inflammation (32 Uygur, 21 Han). Methylation analysis was performed using pyrosequencing to quantitatively assess methylation levels at specified CpG sites within the HPV16 L1 gene.ResultsHigh methylation levels were predominantly observed at sites 5927, 5963 and 6367 in cervical cancer cells compared with inflammatory cells. Methylation patterns exhibited no significant differences between the Han and Uygur ethnic groups but correlated with viral load and age within each group. Receiver operating characteristic curve analyses of these methylation sites indicated high diagnostic accuracy in distinguishing between high-grade lesions and less severe conditions.ConclusionsMethylation of specific CpG sites in the HPV16 L1 gene holds promise as a biomarker for cervical cancer progression. The gene locus at position 6367 has important features in the methylation pattern of cervical cancer, and high accuracy shown in diagnosis make it a potential biomarker for early diagnosis of cervical cancer.https://www.frontiersin.org/articles/10.3389/fonc.2025.1481621/fullhuman papillomavirus 16cervical cancermethylationbiomarkerspyrosequencing
spellingShingle Sha Ji
Nannan Ji
Methylation sites of human papillomavirus 16 as potential biomarkers for cervical cancer progression
Frontiers in Oncology
human papillomavirus 16
cervical cancer
methylation
biomarkers
pyrosequencing
title Methylation sites of human papillomavirus 16 as potential biomarkers for cervical cancer progression
title_full Methylation sites of human papillomavirus 16 as potential biomarkers for cervical cancer progression
title_fullStr Methylation sites of human papillomavirus 16 as potential biomarkers for cervical cancer progression
title_full_unstemmed Methylation sites of human papillomavirus 16 as potential biomarkers for cervical cancer progression
title_short Methylation sites of human papillomavirus 16 as potential biomarkers for cervical cancer progression
title_sort methylation sites of human papillomavirus 16 as potential biomarkers for cervical cancer progression
topic human papillomavirus 16
cervical cancer
methylation
biomarkers
pyrosequencing
url https://www.frontiersin.org/articles/10.3389/fonc.2025.1481621/full
work_keys_str_mv AT shaji methylationsitesofhumanpapillomavirus16aspotentialbiomarkersforcervicalcancerprogression
AT nannanji methylationsitesofhumanpapillomavirus16aspotentialbiomarkersforcervicalcancerprogression